EDGAR Filing Documents for 0001493152-16-016114

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001493152-16-016114

Filing Date

2016-12-21

Accepted

2016-12-21 17:26:08

Documents

Period of Report

2016-08-31

Document Format Files

Seq	Description	Document	Type	Size
1		form10-k.htm	10-K	736876
2		ex31-1.htm	EX-31.1	12915
3		ex31-2.htm	EX-31.2	12934
4		ex32-1.htm	EX-32.1	5417
5		ex32-2.htm	EX-32.2	5499
6		image_001.jpg	GRAPHIC	27645
7		image_002.jpg	GRAPHIC	5856
8		image_003.jpg	GRAPHIC	5121
9		image_004.jpg	GRAPHIC	3742
10		image_005.jpg	GRAPHIC	13562
11		image_006.jpg	GRAPHIC	11940
	Complete submission text file	0001493152-16-016114.txt		2354738

Data Files

Seq	Description	Document	Type	Size
12	XBRL INSTANCE FILE	ptlf-20160831.xml	EX-101.INS	213591
13	XBRL SCHEMA FILE	ptlf-20160831.xsd	EX-101.SCH	24011
14	XBRL CALCULATION FILE	ptlf-20160831_cal.xml	EX-101.CAL	28612
15	XBRL DEFINITION FILE	ptlf-20160831_def.xml	EX-101.DEF	68904
16	XBRL LABEL FILE	ptlf-20160831_lab.xml	EX-101.LAB	199078
17	XBRL PRESENTATION FILE	ptlf-20160831_pre.xml	EX-101.PRE	140397

Mailing Address 433 N. CAMDEN DR. BEVERLY HILLS CA 90210

Business Address 433 N. CAMDEN DR. BEVERLY HILLS CA 90210 (310) 279-5152

PetLife Pharmaceuticals, Inc. (Filer) CIK: 0001354591 (see all company filings)